Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000288893 | SCV000345526 | uncertain significance | not provided | 2016-08-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001859724 | SCV002200544 | benign | Nemaline myopathy 2 | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003343747 | SCV004066226 | uncertain significance | Inborn genetic diseases | 2023-08-04 | criteria provided, single submitter | clinical testing | The c.4835G>A (p.R1612H) alteration is located in exon 41 (coding exon 39) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 4835, causing the arginine (R) at amino acid position 1612 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |